Sonoma Pharmaceuticals (SNOA) Interest Coverage Ratio (2010 - 2026)
Sonoma Pharmaceuticals (SNOA) posted quarterly Interest Coverage Ratio of 87.75 for Q1 2026, up 140.13% year-over-year from 36.54 in Q1 2025, and up 255.31% quarter-over-quarter from 56.5 in Q4 2025.
Sonoma Pharmaceuticals (SNOA) Interest Coverage Ratio (2010 - 2026) Analysis & Trends
Sonoma Pharmaceuticals' Interest Coverage Ratio history runs 17 years deep, the most recent figure standing at 87.75 for Q1 2026.
- In Q1 2026, Interest Coverage Ratio rose 140.13% year-over-year to 87.75; the TTM figure through Mar 2026 stood at 410.17 (down 65.84% YoY), while the FY2026 annual figure was 0.09, up 27.39% from the prior year.
- Interest Coverage Ratio for Q1 2026 stood at 87.75, up from 56.5 in the prior quarter.
- The five-year high for Interest Coverage Ratio was 87.75 in Q1 2026, with the low at 255.0 in Q1 2022.
- The 5-year median for Interest Coverage Ratio is 15.14 (2023), against an average of 62.67.
- The sharpest annual moves came in 2023 and 2026: Interest Coverage Ratio plunged 1750.85% in 2023, then surged 140.13% in 2026.
- Sonoma Pharmaceuticals' Interest Coverage Ratio stood at 3.43 in 2022, then slumped by 622.78% to 24.82 in 2023, then soared by 80.65% to 4.8 in 2024, then tumbled by 1076.53% to 56.5 in 2025, then soared by 255.31% to 87.75 in 2026.
- Business Quant data shows SNOA's Interest Coverage Ratio at 87.75 in Q1 2026, 56.5 in Q4 2025, and 2.59 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | -3.15 |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | 114.07 |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 0.05 |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | 52.24 |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 4.20 |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Sonoma Pharmaceuticals | 5.17 Mn | -165,129.89 | 2.58 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.06 |
| Mar 31, 2026 | 87.75 |
| Dec 31, 2025 | -56.50 |
| Sep 30, 2025 | -2.59 |
| Jun 30, 2025 | -5.45 |
| Mar 31, 2025 | -218.67 |
| Sep 30, 2024 | -4.80 |
| Jun 30, 2024 | -48.88 |
| Mar 31, 2024 | -201.29 |
| Dec 31, 2023 | -24.82 |
| Sep 30, 2023 | -3.09 |
| Jun 30, 2023 | -29.52 |
| Mar 31, 2023 | -229.40 |
| Dec 31, 2022 | -3.43 |
| Sep 30, 2022 | -5.41 |
| Jun 30, 2022 | -1.60 |
| Mar 31, 2022 | -255.00 |
| Dec 31, 2021 | -68.43 |
| Sep 30, 2021 | -1.23 |
| Jun 30, 2021 | -1.13 |